Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal ...

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 5, 2025, the Compensation ...

Overall, the median time from biopsy to treatment was 35 days, but differed significantly between patients whose diagnosis ...

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

NERLYNX was granted marketing authorization by the European Commission in 2018 for the extended adjuvant treatment of adult ...

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck ...

The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) as an adjuvant treatment ... who have had previous endocrine therapy.

The department is also looking to hear from any employees who were disciplined or “threatened” if they refused to participate in certain medical procedures, including abortions or hormone therapy for ...

Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials. Obstetrics & Gynecology , 2025; 145 (4): 357 DOI: 10.1097/AOG ...